TriSalus Life Sciences (TLSI) EBIT Margin (2022 - 2026)
TriSalus Life Sciences posted quarterly EBIT Margin of 94.52% for Q1 2026, down 1457.0% year-on-year from 6.97% in Q1 2025, and down 281.56% on a QoQ basis from 24.77% in Q4 2025.
TriSalus Life Sciences (TLSI) has 5 years of EBIT Margin data on file, last reported at 94.52% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 1457.0% year-over-year to 94.52%; the trailing twelve-month figure through Mar 2026 stood at 62.45% (up 3656.0% YoY), and the FY2025 full-year result was 59.68%, up 6320.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 94.52%, down from 24.77% in the prior quarter.
- Across five years, EBIT Margin topped out at 24.77% in Q4 2025 and bottomed at 364.91% in Q4 2022.
- The 5-year median for EBIT Margin is 118.91% (2024), against an average of 174.09%.
- The widest annual swing landed in 2023, when EBIT Margin tumbled 15173 bps; it then surged 23957 bps in 2024.
- A 5-year view of EBIT Margin shows it stood at 364.91% in 2022, then jumped by 32 bps to 249.05% in 2023, then jumped by 63 bps to 91.76% in 2024, then surged by 73 bps to 24.77% in 2025, then slumped by 282 bps to 94.52% in 2026.
- The last three EBIT Margin figures came in at 94.52% (Q1 2026), 24.77% (Q4 2025), and 77.94% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | TriSalus Life Sciences | 187.09 Mn | 130.54 Mn | 7.67 Mn | -94.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -94.52% |
| Dec 31, 2025 | -24.77% |
| Sep 30, 2025 | -77.94% |
| Jun 30, 2025 | -65.39% |
| Mar 31, 2025 | -79.95% |
| Dec 31, 2024 | -91.76% |
| Sep 30, 2024 | -118.91% |
| Jun 30, 2024 | -111.00% |
| Mar 31, 2024 | -180.77% |
| Dec 31, 2023 | -249.05% |
| Sep 30, 2023 | -358.48% |
| Jun 30, 2023 | -247.92% |
| Mar 31, 2023 | -339.18% |
| Dec 31, 2022 | -364.91% |
| Sep 30, 2022 | -206.76% |